Veraxa Biotech Holding AG (VRXA) Long-Term Deferred Tax (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Long-Term Deferred Tax for 2 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Deferred Tax rose 28.57% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 28.57% YoY), and the FY2025 full-year result was $2.1 million, up 28.57% from the prior year.
• Long-Term Deferred Tax climbed to $2.1 million in Q4 2025 per VRXA's latest filing, from $1.6 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.1 million in Q4 2025 to a low of $1.6 million in Q4 2024.